Form 4: Arvinas CFO Andrew Saik Receives Stock Options and Restricted Stock Units

Andrew Saik, CFO of Arvinas, Inc., was granted stock options and restricted stock units on May 9, 2025, according to a recent SEC filing.

Summary

• Andrew Saik, the Chief Financial Officer of Arvinas, Inc., received stock options and restricted stock units (RSUs) on May 9, 2025.
• The RSUs, totaling 59,600, were granted under the company's 2018 Stock Incentive Plan and represent the right to receive one share of Arvinas common stock per RSU upon settlement.
• These RSUs will vest over two years, with half vesting on May 9, 2026, and the remaining half on May 9, 2027, contingent upon continued service with Arvinas.
• Saik also received options to purchase 91,000 shares of Arvinas common stock at an exercise price of $6.61 per share.
• These options also vest over two years, with the same vesting schedule as the RSUs: half on May 9, 2026, and the remainder on May 9, 2027, subject to continued service.
• Following these transactions, Saik directly owns 170,101 shares of Arvinas common stock and options to purchase 91,000 shares.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, indicating stability and alignment of interests. It's a neutral-positive event.

Positives

• The grant of RSUs and stock options to the CFO aligns his interests with those of the shareholders.
• The vesting schedule incentivizes continued service and commitment to the company's long-term success.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the granted securities.

Industry Context

Grants of stock options and restricted stock units are common practices in the biotechnology industry to attract, retain, and incentivize key executives.

Comparison to Industry Standards

• Stock option and RSU grants are a standard component of executive compensation packages in the biotech industry.
• Companies like Amgen, Gilead, and Biogen also utilize similar equity-based compensation plans to align executive incentives with shareholder value.
• The vesting schedules are typical, often spanning two to four years to encourage long-term commitment.

Stakeholder Impact

• The grant of equity to the CFO aligns his interests with those of shareholders, potentially leading to decisions that benefit the company's long-term value.
• Employees may view this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

Arvinas, Andrew Saik, CFO, stock options, restricted stock units, RSUs, insider trading, SEC Form 4, ARVN, vesting